New insights on the role of the retina in diagnostic and therapeutic strategies in major depressive disorder.

Neuroscience and Biobehavioral Reviews
Eve CoskerThomas Schwitzer

Abstract

Major depressive disorder (MDD) affects people worldwide. MDD treatments include antidepressants, which involve a delayed onset of action, long-term treatment, side effects and, frequently, only partial efficacy. The lack of access to the living brain, and the complex and still poorly elucidated pathophysiology of MDD, hinders treatment development. There is not only a need for new treatment strategies, but also for new approaches to investigating the pathophysiology of MDD. Light therapy is a well-established treatment acting through the retina. Since the retina is part of the central nervous system, it has been suggested as a useful area for investigating mental illness. In this article, we will first set out the evidence that MDD affects the retina's structure and function. We will then review studies evaluating the efficacy of light therapy in unipolar non-seasonal MDD. Finally, we discuss the disruption of melatoninergic pathways in MDD, its assessment through the retina and the treatment of this disruption with light therapy.

References

Feb 25, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·J N GieddN E Rosenthal
Jul 17, 1998·Vision Research·S M Wu, B R Maple
Jun 3, 1999·Acta Psychiatrica Scandinavica·T M Lee, C C Chan
Oct 25, 2003·Psychoneuroendocrinology·M CrassonJ J Legros
Apr 24, 2004·Documenta Ophthalmologica. Advances in Ophthalmology·Paul Witkovsky
Jun 24, 2004·International Journal of Geriatric Psychiatry·Yun-Fang TsaiHsiu-Hsin Tsai
Nov 6, 2004·Acta Psychiatrica Scandinavica. Supplementum·K Martiny
Feb 24, 2005·Journal of Pineal Research·Jennifer L Peters, Vincent M Cassone
Apr 1, 2005·The American Journal of Psychiatry·Robert N GoldenCharles B Nemeroff
Apr 23, 2005·Annals of General Psychiatry·Konstantinos N FountoulakisGeorge Kaprinis
Aug 30, 2005·Issues in Mental Health Nursing·Geoffry W McEnany, Kathryn A Lee
Aug 1, 2006·Current Eye Research·Matthew J GastingerDavid W Marshak
Aug 19, 2007·Archives of Women's Mental Health·M CorralS Patton
Jan 4, 2008·The New England Journal of Medicine·R H Belmaker, Galila Agam
Aug 6, 2008·Human Psychopharmacology·Anne Germain, David J Kupfer
Nov 26, 2008·Documenta Ophthalmologica. Advances in Ophthalmology·M F MarmorUNKNOWN International Society for Clinical Electrophysiology of Vision
Nov 20, 2009·Journal of Circadian Rhythms·Anne-Marie GagnéMarc Hébert
Feb 12, 2010·Documenta Ophthalmologica. Advances in Ophthalmology·J LavoieM Hébert
Mar 30, 2010·Journal of Biological Rhythms·Karine ScheuermaierJeanne F Duffy
Apr 3, 2010·Biological Psychiatry·Emanuel BublLudger Tebartz van Elst
Jun 19, 2010·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Graham E HolderUNKNOWN International Federation of Clinical Neurophysiology
Aug 10, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Palmiero MonteleoneMario Maj
May 4, 2011·The Journal of Clinical Psychiatry·Anna Wirz-JusticeAnita Riecher-Rössler
Aug 9, 2011·Biological Psychiatry·Gilles VandewalleJulie Carrier
Sep 15, 2011·Journal of Physiology, Paris·Paul Pevet, Etienne Challet
Nov 1, 2011·Documenta Ophthalmologica. Advances in Ophthalmology·Donald C HoodUNKNOWN International Society For Clinical Electrophysiology of Vision
Apr 10, 2012·Annual Review of Neuroscience·Jennifer A MohawkJoseph S Takahashi
Jun 16, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Emanuel BublMichael Bach
Sep 19, 2012·Progress in Retinal and Eye Research·Hai HuangXiong-Li Yang
Oct 18, 2012·Documenta Ophthalmologica. Advances in Ophthalmology·Michael BachSuresh Viswanathan
Nov 21, 2012·Nature Reviews. Neurology·Anat LondonMichal Schwartz
Jan 1, 2013·International Review of Cell and Molecular Biology·Allan F Wiechmann, David M Sherry
Jan 15, 2013·Neuroscience and Biobehavioral Reviews·Marta MiretEduard Vieta
Jan 22, 2013·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Clairton F de SouzaMichael Kalloniatis
Jun 4, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Pierre M BetWitte J G Hoogendijk
Jun 12, 2013·Journal of Psychosomatic Research·Johnson FamChi Luu
Oct 15, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Joëlle LavoieMarc Hébert
Nov 16, 2013·The Psychiatric Clinics of North America·Kara ZivinOla Rostant
Dec 20, 2013·Depression and Anxiety·Mark J NiciuCarlos A Zarate
Jan 9, 2014·Chronobiology International·Mark A Oldham, Domenic A Ciraulo
Apr 24, 2014·Ophthalmology·Giovanni StaurenghiUNKNOWN International Nomenclature for Optical Coherence Tomography (IN•OCT) Panel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.